Globe Life/$GL
1D1W1MYTD1Y5YMAX
Capital at risk
About Globe Life
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
- Ticker
- $GL
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 3,695
- Headquarters
- McKinney, United States
- Website
- home.globelifeinsurance.com
Globe Life Metrics
BasicAdvanced
$13B
11.42
$15.08
0.47
$1.20
0.77%
Price and volume
Market cap
$13B
Beta
0.47
52-week high
$191.55
52-week low
$127.85
Average daily volume
439K
Dividend rate
$1.20
Financial strength
Current ratio
0.795
Quick ratio
0.64
Long term debt to equity
0.512
Total debt to equity
0.557
Dividend payout ratio (TTM)
7.47%
Interest coverage (TTM)
11.66%
Profitability
EBITDA (TTM)
1,685.561
Gross margin (TTM)
33.91%
Net profit margin (TTM)
19.58%
Operating margin (TTM)
26.63%
Effective tax rate (TTM)
18.95%
Revenue per employee (TTM)
$1,680,000
Management effectiveness
Return on assets (TTM)
3.36%
Return on equity (TTM)
20.95%
Valuation
Price to earnings (TTM)
11.424
Price to revenue (TTM)
2.198
Price to book
2.21
Price to tangible book (TTM)
2.34
Price to free cash flow (TTM)
11.045
Free cash flow yield (TTM)
9.05%
Free cash flow per share (TTM)
15.596
Dividend yield (TTM)
0.70%
Forward dividend yield
0.77%
Growth
Revenue change (TTM)
5.24%
Earnings per share change (TTM)
20.22%
3-year revenue growth (CAGR)
5.45%
10-year revenue growth (CAGR)
4.87%
3-year earnings per share growth (CAGR)
19.09%
10-year earnings per share growth (CAGR)
13.24%
3-year dividend per share growth (CAGR)
11.53%
10-year dividend per share growth (CAGR)
8.11%
What the Analysts think about Globe Life
Analyst ratings (Buy, Hold, Sell) for Globe Life stock.
Analyst projections of the future price of Globe Life stock.
Bulls say / Bears say
Globe Life posted a nearly 20% increase in second-quarter net profit, driven by strong underwriting performance and higher investment income. (Reuters)
Second-quarter revenue rose 7% year-over-year to $1.60 billion, topping analysts’ $1.59 billion consensus forecast and demonstrating consistent top-line momentum. (Reuters)
Health premium revenue climbed 16% year-over-year to $437 million in the quarter, underscoring robust growth in the higher-margin supplemental health segment. (Reuters)
Net operating income per share of $3.61 missed the $3.67 consensus by 1.6%, marking a rare earnings miss and triggering a 7.7% after-hours share decline. (Reuters)
Health underwriting margin compressed to 23% of premiums from 26% a year earlier, reflecting increased claims pressure in the supplemental health business. (Reuters)
American Income Life’s average producing agent count declined 7% year-over-year, posing a risk to sales momentum in a core distribution channel. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 29 Aug 2026.
Globe Life Financial Performance
Revenues and expenses
Globe Life Earnings Performance
Company profitability
Upcoming events
Globe Life News
AllArticlesVideos
Funds containing Globe Life
AllEURGBPUSD
Fund name | Fund size | $GL weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.52% |
SPDR S&P US Dividend Aristocrats€SPYD | €3.3B | 0.31% |
SPDR S&P US Dividend Aristocrats£USDV | £2.8B | 0.31% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.26% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.26% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.